RSS Feed For (NY:BVF)

BIOVAIL CORPORATION (NY:BVF)

14.24 +0.14 (0.99%)
BIOVAIL CORPORATION (NY:BVF) Delayed :
Previous Close $14.10    52 Week High $15.50 
Open $14.06    52 Week Low $7.35 
Day High $14.25    P/E N/A 
Day Low $13.92    EPS $0.00 
Volume 681,512       
More BVF Info: Chart SEC Filings Profile Historical Options

Biovail Corp. Summary

Biovail Corporation engages in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products utilizing various drug-delivery technologies in the United States and Canada. The company principally focuses on central nervous system disorders, pain management, and cardiovascular ...more

Executives

Doug Squires - Interim Chairman, CEO

Links

http://www.biovail.com/


What is this?Friends, Peers and Foes

Ticker # Stories Ticker # Stories
ACAD 7 CROX 4
PRX 3 NVO 3
CDII 2 CBS 2
DTV 2 CAH 2
TEVA 2 USM 2
CLR 2 UTSI 2
View All Friends, Peers and Foes

Entities who have mentioned BVF

View All Entities

View All Major News StreetInsider.com Major News for BVF

Nov 5, 2009 08:25 AM Biovail (BVF) Tops Q3 EPS by 21c, Revs Light
Aug 6, 2009 07:07 AM Biovail (BVF) Reports Cash EPS of $0.59
May 6, 2009 08:07 AM Biovail (BVF) Reports Mixed Q1 Earnings; Will Acquire US Commercialization Rights to Wellbutrin XL(R); Cuts Qtr. Dividend to $0.09/Share
View All Major News

View All ReportsStreetInsider.com Reports on BVF

Nov 5, 2009 08:25 AM Biovail (BVF) Tops Q3 EPS by 21c, Revs Light
Nov 4, 2009 02:42 PM Trading Radar for 11/05: Starbucks (SBUX), CBS Corp. (CBS), CVS (CVS), Toyota (TM), Thomson Reuters (TRI)
Oct 6, 2009 07:28 AM Biovail (BVF) Provides Update to Its Phase III Program with Pimavanserin for PDP - Study Doesn't Meet Primary Endpoint
Sep 30, 2009 07:31 AM Goldman Sachs Raises Price Targets for Healthcare Services; Upgrades ABC, Downgrades PSSI
Sep 25, 2009 08:02 AM J.P. Morgan Initiates Coverage on Biovail (BVF) with an Overweight
View All Reports

View All Press ReleasesCompany Press Releases on BVF

Nov 10, 2009 01:57PM Biovail to Participate at Upcoming Conferences
Nov 5, 2009 07:00AM Biovail Reports Third-Quarter 2009 Financial Results
Nov 5, 2009 06:59AM Biovail Declares Quarterly Dividend
Oct 23, 2009 10:00AM Biovail Announces Third-Quarter 2009 Earnings Release, Conference-Call Details
Oct 7, 2009 06:50AM StockPreacher.com Issues Trading Outlook for DepoMed Inc.
View All Press Releases

StreetInsider Reports on BVF by Category

View All BlogsBlogs on BVF

Sep 2, 2009 09:07 AM Take Advantage of Biovail Weakness - RBC
Aug 30, 2009 09:56 AM Several Promising Deals for Biotech
Aug 24, 2009 03:40 PM Biovail's short selling lawsuit dismissed
Aug 24, 2009 12:47 PM Biovail Makes Good on Promise to Transform into Niche Player in CNS Diseases
Aug 24, 2009 04:58 AM A (Bio)Vail of Tears: Junk Lawsuit Against SAC Capital Thrown Out
View All Blogs

View All FilingsSEC Filings on BVF

Nov 6, 2009 05:08PM Form 6-K BIOVAIL CORP INTERNATION For: Sep 30
Nov 5, 2009 04:04PM Form 6-K BIOVAIL CORP INTERNATION For: Nov 05
Nov 5, 2009 04:01PM Form 6-K BIOVAIL CORP INTERNATION For: Nov 05
Oct 6, 2009 02:26PM Form 6-K BIOVAIL CORP INTERNATION For: Oct 06
View All Filings

Comments on recent BVF articles

jghj
on May 13, 2008
at 09:47 AM ghjgjg buy xanax without a prescription Buy Meridia Without a Prescription xenical prescription online order oxycontin ordering cialis from canada
Article: Biovail (BVF) Comments on New York Post Article - Intends to Proceed with Lawsuit Against Group of Hedge Funds

Comments on BVF


No comments are currently available.